myelodysplastic syndromes (MDS) | Page 6 | Aplastic Anemia & MDS International Foundation Return to top.

myelodysplastic syndromes (MDS)

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Author(s): 
Gorak EJ, Otterstatter M, Al Baghdadi T, Gillis N, Foran JM, Liu JJ, Bejar R, Gore SD, Kroft SH, Harrington A, Saber W, Starczynowski D, Rollison DE, Zhang L, Moscinski L, Wilson S, Thompson J, Borchert C, Sherman S, Hebert D, Walker ME, Padron E,
Primary Author: 
Gorak EJ
Journal Title: 
Blood Advances
Original Publication Date: 
Oct 2023

Myelodysplastic neoplasms (MDS) are a collection of hematopoietic disorders with widely variable prognoses and treatment options. Accurate pathologic diagnoses present challenges because of interobserver variability in interpreting morphology and quantifying dysplasia.

Bone Marrow Disease(s): 

Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

Author(s): 
Mukherjee S, Dong W, Schiltz NK, Stange KC, Cullen J, Gerds AT, Carraway HE, Singh A, Advani AS, Sekeres MA, Koroukian SM
Primary Author: 
Mukherjee S
Journal Title: 
Oncologist
Original Publication Date: 
Oct 2023

Background: Older patients with

Bone Marrow Disease(s): 

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT

Author(s): 
Gurnari C, Robin M, Godley LA, Drozd-Sokołowska J, Włodarski MW, Raj K, Onida F, Worel N, Ciceri F, Carbacioglu S, Kenyon M, Aljurf M, Bonfim C, Makishima H, Niemeyer C, Fenaux P, Zebisch A, Hamad N, Chalandon Y, Hellström-Lindberg E, Voso MT, Mecucci C,
Primary Author: 
Gurnari C,
Journal Title: 
Lancet Hematology
Original Publication Date: 
Oct 2023

The recent application of whole exome or whole genome sequencing unveiled a plethora of germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms. The presence of such variants in patients with

Bone Marrow Disease(s): 

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

Author(s): 
Oliva EN, Riva M, Niscola P, Santini V, Breccia M, Giai V, Poloni A, Patriarca A, Crisà E, Capodanno I, Salutari P, Reda G, Cascavilla N, Ferrero D, Guarini A, Tripepi G, Iannì G, Russo E, Castelli A, Fattizzo B, Beltrami G, Bocchia M, Molteni A, Fenaux P
Primary Author: 
Oliva EN
Journal Title: 
Journal of Clinical Oncology
Original Publication Date: 
Oct 2023

Purpose: In

Bone Marrow Disease(s): 

Aplastic Anemia, MDS, and PNH Virtual Support Group -Saturdays- 2023 December

Event Date: 
Sat, 12/16/2023 - 10:30am (EST)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Share with addtoany.com.